Literature DB >> 10520914

Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations.

J F Moley1, T C Lairmore, G M Doherty, L M Brunt, M K DeBenedetti.   

Abstract

BACKGROUND: The recurrent laryngeal nerve (RLN) is vulnerable to injury in thyroid and parathyroid reoperations because of the presence of scar tissue and displacement of the nerve from its normal position.
METHODS: Since 1993, we have performed 132 reoperations for recurrence of thyroid or parathyroid carcinoma (102 cases), persistent hyperparathyroidism (21 cases), and recurrent goiter (9 cases). One or both RLNs were identified in all cases (208 nerves). Exposure of the nerve was accomplished by a lateral approach (159 nerves), a low anterior approach (41 nerves), or the identification of the nerve between the larynx and the upper pole of the thyroid, in parathyroid reoperations (8 nerves). Dissection was then done while the nerve was kept in view at all times.
RESULTS: Preoperatively, unilateral vocal cord paralysis was noted in 6 patients. Resection of a functioning RLN encased with a tumor was intentionally carried out in 5 patients. The RLNs were identified and preserved in all other cases. Among these 121 patients, transient hoarseness lasting up to a month occurred in 12 patients.
CONCLUSIONS: Careful identification and exposure of the RLN through a previously undissected area can be done safely in thyroid and parathyroid reoperations and resulted in no permanent recurrent nerve injuries in our experience.

Entities:  

Mesh:

Year:  1999        PMID: 10520914

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Intrathyroidal parathyroid carcinoma in a pediatric patient.

Authors:  Alvaro Antonio Herrera-Hernández; Paola Aranda-Valderrama; Julio Alexander Díaz-Pérez; Loren Paola Herrera
Journal:  Pediatr Surg Int       Date:  2011-04-26       Impact factor: 1.827

2.  Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.

Authors:  Amanda M Laird; Paul G Gauger; Barbra S Miller; Gerard M Doherty
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 3.  Complications after reoperative thyroid surgery: retrospective evaluation of 152 consecutive cases.

Authors:  Fabio Medas; Massimiliano Tuveri; Gian Luigi Canu; Ernico Erdas; Pietro Giorgio Calò
Journal:  Updates Surg       Date:  2019-04-01

Review 4.  Central lymph node dissection in differentiated thyroid cancer.

Authors:  Matthew L White; Paul G Gauger; Gerard M Doherty
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

5.  Complications in thyroid surgery for carcinoma: one institution's surgical experience.

Authors:  Antonio Toniato; Isabella Merante Boschin; Andrea Piotto; Maria Rosa Pelizzo; Annamaria Guolo; Mirto Foletto; Eric Casalide
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

6.  Remedial operation for primary hyperparathyroidism.

Authors:  Jason D Prescott; Robert Udelsman
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

7.  Central compartment neck dissection for thyroid cancer: a surgical technique.

Authors:  Dana M Hartl; Jean-Paul Travagli
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

8.  Continuous intraoperative nerve monitoring in thyroidectomy using automatic periodic stimulation in 256 at-risk nerves.

Authors:  N Hamilton; H Morley; M Haywood; S Arman; G Mochloulis
Journal:  Ann R Coll Surg Engl       Date:  2019-06-03       Impact factor: 1.891

9.  Morbidity of central neck dissection: primary surgery vs reoperation. Results of a case-control study.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Carmela De Crea; Luca Sessa; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

Review 10.  Sporadic and familial medullary thyroid carcinoma: state of the art.

Authors:  Tricia A Moo-Young; Amber L Traugott; Jeffrey F Moley
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.